Stenger says Newport plans are on track
copyright the Chronicle April 6, 2016
by Joseph Gresser
NEWPORT – Bill Stenger says his plans for Newport are on track, although those related to the AnC Bio facility are undergoing some modifications in reaction to changes in the direction of biomedical technology.
In a conversation Monday, just after he returned from seeking investors in South Africa, Mr. Stenger said plans have been modified to allow the facility to manufacture products for gene therapy products in addition to those based on stem cells.
Gene therapy requires changes to “air flow, water flow, and people flow” in the plant, he said.
Mr. Stenger said the design modifications are necessary to keep pace…To read the rest of this article, and all the Chronicle‘s stories, subscribe:
Annual online subscription
Short-term online subscription
(To find a particular article, search for the corresponding edition of the newspaper)